QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
1-Year Return
19.13%
This Quarter Return
+2.93%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$1.35B
AUM Growth
+$80.3M
(+6.3%)
Cap. Flow
+$61.4M
Cap. Flow
% of AUM
4.56%
Top 10 Holdings %
Top 10 Hldgs %
36.29%
Holding
2,807
New
90
Increased
1,312
Reduced
822
Closed
107
Top Buys
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$15.1M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.11M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.34M |
| 4 |
Apple
AAPL
|
+$3.13M |
| 5 |
Microsoft
MSFT
|
+$2.61M |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$7.48M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.13M |
| 3 |
GRDI
GRIID Infrastructure Inc. Common Stock
GRDI
|
+$1.93M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$754K |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$692K |
Sector Composition
| 1 | Technology | 17.12% |
| 2 | Financials | 7.89% |
| 3 | Healthcare | 6.92% |
| 4 | Consumer Staples | 5.98% |
| 5 | Consumer Discretionary | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Pacira BioSciences
PCRX
$1.22B
| $13.9K | ﹤0.01% |
487
-839
| -63% | -$24K |
|
2002
CEVA Inc
CEVA
$562M
| $13.9K | ﹤0.01% |
719
-730
| -50% | -$14.1K |
|
2003
LSI Industries
LYTS
$676M
| $13.9K | ﹤0.01% |
958
| – | – |
|
2004
Mercer International
MERC
$209M
| $13.9K | ﹤0.01% |
1,622
-49
| -3% | -$418 |
|
|
MCBC
2005
DELISTED
Macatawa Bank Corp
MCBC
| $13.8K | ﹤0.01% |
946
+792
| +514% | +$11.6K |
|
2006
Endava
DAVA
$536M
| $13.8K | ﹤0.01% |
471
-678
| -59% | -$19.8K |
|
2007
Intellia Therapeutics
NTLA
$1.24B
| $13.7K | ﹤0.01% |
613
+231
| +60% | +$5.17K |
|
2008
1st Source
SRCE
$1.57B
| $13.7K | ﹤0.01% |
+255
| New | +$13.7K |
|
2009
Liberty Broadband Class C
LBRDK
$8.7B
| $13.6K | ﹤0.01% |
248
-2
| -0.8% | -$110 |
|
2010
Krystal Biotech
KRYS
$4.16B
| $13.6K | ﹤0.01% |
74
+39
| +111% | +$7.16K |
|
|
BECN
2011
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $13.6K | ﹤0.01% |
150
| – | – |
|
2012
United Natural Foods
UNFI
$1.79B
| $13.6K | ﹤0.01% |
1,035
+661
| +177% | +$8.66K |
|
2013
Booz Allen Hamilton
BAH
$12.9B
| $13.5K | ﹤0.01% |
88
+1
| +1% | +$154 |
|
2014
EPAM Systems
EPAM
$8.74B
| $13.5K | ﹤0.01% |
72
-171
| -70% | -$32.2K |
|
|
BELFB
2015
Bel Fuse Class B
BELFB
$1.83B
| $13.5K | ﹤0.01% |
207
-130
| -39% | -$8.48K |
|
2016
Akero Therapeutics
AKRO
$3.55B
| $13.4K | ﹤0.01% |
573
-146
| -20% | -$3.43K |
|
2017
Rush Street Interactive
RSI
$2.01B
| $13.3K | ﹤0.01% |
1,391
| – | – |
|
2018
Hexcel
HXL
$4.97B
| $13.3K | ﹤0.01% |
213
+2
| +0.9% | +$125 |
|
2019
ScottsMiracle-Gro
SMG
$3.51B
| $13.3K | ﹤0.01% |
204
-1
| -0.5% | -$65 |
|
2020
Texas Pacific Land
TPL
$21.7B
| $13.2K | ﹤0.01% |
+18
| New | +$13.2K |
|
2021
Ironwood Pharmaceuticals
IRWD
$206M
| $13.2K | ﹤0.01% |
2,026
-3,577
| -64% | -$23.3K |
|
2022
SoFi Technologies
SOFI
$31.2B
| $13.2K | ﹤0.01% |
1,994
+1,318
| +195% | +$8.71K |
|
2023
Capital Southwest
CSWC
$1.27B
| $13.1K | ﹤0.01% |
503
+47
| +10% | +$1.23K |
|
2024
Enovis
ENOV
$1.84B
| $13.1K | ﹤0.01% |
290
-70
| -19% | -$3.16K |
|
2025
Chegg
CHGG
$173M
| $13K | ﹤0.01% |
+4,122
| New | +$13K |
|